definiens: means ( i ) those patent applications listed in Part A of Schedule 2 under the title ‘ FIX Patents ’ and all Patent Rights derived therefrom ; and ( ii ) any Future Patents filed in respect of any of the Program Know -How identified in ( ii ) of the definition of FIX Program IP, and ( iii ) the [ * * ] Patent Rights ; means, excluding Additional Royalty Products, any AAV -directed gene therapy product which is indicated ( by way of its product label or package insert ) for use in the FIX Field and is Cover ed by any of the FIX Program IP, [ * * ] Program IP, Manufacturing Know -How, Serotype IP and/or Promoter Program IP licensed to Liverco hereunder ; means the program of research defined in Schedule 1 under the title FIX Program as conducted prio r to the Effective Date ; means the ( i ) FIX Patent Rights and ( ii ) Program Know -How applicable to Exploitation within the FIX Field ; means the treatment, prevention, cure, management, diagnosis and/or control of conditions concerning or related to [ * * ], including the condition the condition referred to as ‘ [ * * ] ’, and associated symptoms ; has the meaning set out in Claus e 2.4.3 ; means ( i ) those patent applications listed in Part A of Schedule 2 under the title ‘ [ * * ] ’ and all Patent Rights derived therefrom ; and ( ii ) any Future Patents filed in respect of any of the Program Know -How identified in ( ii ) of the definition of [ * * ] ; means, excluding Additional Royalty Products, any AAV -directed gene therapy product which is indicated for use ( by way of its product label or package insert ) in the [ * * ] and is Covered by any of the [ * * ], Manufa cturing Know -How, Serotype IP and/or Promoter Program IP licensed to Liverco hereunder ; means the program of research defined in Schedule 1 under the title [ * * ] as conducted prior to the Effective Date ; means the ( i ) [ * * ] Patent Rights and ( ii ) Program Know -How applicable to Exploitation within the [ * * ] Field ; means ( i ) a vector that [ * * ], or ( ii ) a vector that [ * * ] that [ * * ] ; 10 Certain confidential information contained in this document, marked by [ * * ], has been omitted because the information ( i ) is not material and ( ii ) would likely cause competitive harm to the Company if publicly disclosed